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ABSTRACT The efﬁcacy of current antimalarial drugs is threatened by reduced suscep-
tibility of Plasmodium falciparum to artemisinin, associated with mutations in pfkelch13.
Another gene with variants known to modulate the response to artemisinin encodes the
 subunit of the AP-2 adaptin trafﬁcking complex. To elucidate the cellular role of
AP-2 in P. falciparum, we performed a conditional gene knockout, which severely dis-
rupted schizont organization and maturation, leading to mislocalization of key merozoite
proteins. AP-2 is thus essential for blood-stage replication. We generated transgenic P.
falciparum parasites expressing hemagglutinin-tagged AP-2 and examined cellular lo-
calization by ﬂuorescence and electron microscopy. Together with mass spectrometry
analysis of coimmunoprecipitating proteins, these studies identiﬁed AP-2-interacting
partners, including other AP-2 subunits, the K10 kelch-domain protein, and PfEHD, an ef-
fector of endocytosis and lipid mobilization, but no evidence was found of interaction
with clathrin, the expected coat protein for AP-2 vesicles. In reverse immunoprecipita-
tion experiments with a clathrin nanobody, other heterotetrameric AP-complexes were
shown to interact with clathrin, but AP-2 complex subunits were absent.
IMPORTANCE We examine in detail the AP-2 adaptin complex from the malaria para-
site Plasmodium falciparum. In most studied organisms, AP-2 is involved in bringing ma-
terial into the cell from outside, a process called endocytosis. Previous work shows that
changes to the  subunit of AP-2 can contribute to drug resistance. Our experiments
show that AP-2 is essential for parasite development in blood but does not have any
role in clathrin-mediated endocytosis. This suggests that a specialized function for AP-2
has developed in malaria parasites, and this may be important for understanding its im-
pact on drug resistance.
KEYWORDS Plasmodium falciparum, adaptin trafﬁcking complex, artemisinin
susceptibility, adaptor proteins, endocytosis, malaria
Despite important improvements in intervention tools, malaria remains a signiﬁcantcause of infection and death worldwide, particularly in sub-Saharan Africa. Anti-
malarial drugs are indispensable components of malaria control, but historical and
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emerging trends in parasite drug resistance threaten control strategies (1). In uncom-
plicated Plasmodium falciparum infections, clinical treatment failure following artemis-
inin combination therapy (ACT) now occurs throughout the Greater Mekong subregion
(2–6), with some evidence of decreasing ACT effectiveness in Africa (7–11).
The activity of artemisinin has been linked to parasite hemoglobin metabolism.
Heme-derived iron is believed to activate the artemisinin endoperoxide bridge (12),
producing oxygen radicals (13). Treatment with protease inhibitors or disruption of
falcipain proteases that metabolize hemoglobin reduce parasite susceptibility to arte-
misinin (14). Mutations in the food vacuole (FV) membrane chloroquine resistance
transporter (CRT) reduce susceptibility to chloroquine and piperaquine (15–19), and
lineages harboring additional copies of the gene encoding plasmepsin II, another FV
protease, have reduced susceptibility to piperaquine (20, 21). However, despite the
importance to drug action and intraerythrocytic parasite growth, the mechanisms of
uptake of host hemoglobin and transport to the FV are poorly understood. Electron
microscopy (EM) studies suggest that hemoglobin enters the asexual parasite through
various endocytic events and that hemoglobin is ﬁrst taken up into small vesicles that
form the FV (22, 23). Uptake of host cell components by parasite cytosolic compart-
ments involves some bound by membranes containing phosphoinositide 3-phosphate
(PI3P) (24), a marker of endosomal membranes implicated in P. falciparum artemisinin
resistance attributed to variants in the propeller region of the kelch domain protein K13
(24–26). Recently, K13 has itself been localized by green ﬂuorescent protein (GFP)
tagging to cytoplasmic and peripheral foci in close proximity to the parasite’s FV (27),
which may represent the parasite cytostome (28).
In eukaryotes, the process of substrate-speciﬁc endocytosis involves clathrin-coated
vesicles typically assembled with the adaptor protein 2 (AP-2) complex, a heterote-
tramer that mediates cargo selection and recruits clathrin to form a coat (29–32).
Adaptin functions, which are supported by up to six distinct complexes in some
eukaryotes, and clathrin-mediated trafﬁcking have not been analyzed in detail in
apicomplexans (29, 33). Although AP-2 has never been studied, the clathrin heavy chain
has been localized to post-Golgi secretory structures in the related organism Toxo-
plasma gondii; some of these are also positive for the AP-1 adaptor complex (34–37).
Although no endocytic role in apicomplexan trafﬁcking has been elucidated for clathrin
to date, a priori AP-2 remains a likely partner of clathrin in P. falciparum.
Our recent data indicate that P. falciparum expressing variants of the  subunit of
AP-2 display reduced susceptibility to artemisinin in vivo and in vitro (38–40), potentially
linking endocytosis to resistance. Given the importance of hemoglobin uptake to
parasite survival and drug action in Plasmodium, the endocytic function of AP-2 across
taxa, and the conﬁrmed role of AP-2 in artemisinin susceptibility, we sought evidence
that AP-2 contributes to clathrin-mediated hemoglobin uptake during asexual para-
site development in vitro.
RESULTS
AP-2 is localized in the cytosol near the FV and plasma membrane. Based on
conservation of endocytic machinery across eukaryotic taxa, we expected that AP-2
would be localized to the parasite periphery where uptake of host cytosol and
hemoglobin would occur. A C-terminal triple hemagglutinin (3xHA) epitope tag was
introduced by Cas9 editing (Fig. 1A to C) and the localization of AP-2-3xHA examined
by immunoﬂuorescence assay (IFA) across the asexual blood stages in two independent
clones (AP-2-3xHA_c1 and AP-2-3xHA_c2; Fig. 1B). AP-2-3xHA distribution was
comparable in both clones, so only data from the ﬁrst clone are presented.
Throughout the asexual cycle, we observed AP-2-3xHA localizing to punctate
structures in the parasite cytoplasm (Fig. 1D). In ring-stage trophozoites, AP-2 ap-
peared as a single cytosolic focus. These foci increased in number as development
proceeded and also localized to a cytoplasmic compartment adjacent to the FV in older
trophozoites (Fig. 1D, middle row). AP-2 never labeled the FV membrane. During
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schizogony, the AP-2-labeled structures appeared to replicate and segment into
individual daughter merozoites (Fig. 1D, third row).
The cellular distribution of AP-2 was examined further with respect to a panel of
representative organelle markers. The distribution of AP-2 signal did not overlap with
the endoplasmic reticulum (ER), Golgi, or apicoplast markers during development or
FIG 1 P. falciparum AP-2 is localized to a noncanonical cytoplasmic compartment. (A) Homologous repair construct used to install AP-2 variants to fuse a
tandem triple hemagglutinin tag (3xHA) onto the C terminus of AP-2. (B) PCR-based genotyping of two parasite clones harboring AP-2-3xHA in place of the
endogenous AP-2 allele. Ampliﬁcation of the integrated transgenic pfap2 locus with P3 and P2 (annealing sites annotated) produces an 862-bp fragment.
Genotypes were conﬁrmed by Sanger sequencing of the PCR products shown. (C) Anti-HA Western blot conﬁrming expression of the desired fusion protein
(78 kDa) in mixed-stage lysates, compared to wild-type parental 3D7. Molecular weights are presented in kDa. (D) Localization of AP-2-3xHA (green) across
the asexual life cycle by anti-HA IFA, counterstained for parasite DNA with DAPI (blue). The images shown are representative of more than 100 cells examined
at each stage; merge is the superimposition of each channel on a brightﬁeld image (WF). Maximum intensity z-projections are shown. Scale bar, 2 m. (E)
Immunoelectron micrograph of a representative young intraerythrocytic trophozoite. AP-2-3xHA parasites probed with an anti-HA rabbit antibody and a
secondary antibody 18 nm gold conjugate. Protein disulﬁde isomerase (PDI), a marker for the parasite ER, is detected by an anti-PDI mouse antibody and a
secondary conjugated to 12-nm gold particles (Fig. S2, S3, S4, and Table S1). N, nucleus; FV, food vacuole; H, hemazoin; PM/PV, plasma membrane/
parasitophorous vacuole; empty arrows, AP-2 associated with vesicles; black arrows, AP-2 at the plasma membrane; white-outlined arrows, AP-2 in the
cytosol. Scale bar, 500 nm. (F) Localization of AP-2-3xHA (green) with respect to episomally expressed GFP-K13 (red) across the asexual life cycle by IFA.
Representative images of more than 100 observed cells is shown. Maximum intensity z-projections are shown. Scale bar, 2 m.
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with the apical secretory organelles during schizogony (see Fig. S1 in the supplemental
material).
To better characterize the localization of AP-2, we performed immunoelectron
microscopy (immuno-EM) on thin sections of trophozoites expressing AP-2-3xHA. In
an analysis of 66 micrographs of single parasite-infected erythrocytes, gold particles
detecting anti-hemagglutinin (anti-HA) antibodies bound to AP-2-3xHA were ob-
served near the ER (73.8% of micrographs), in vesicles in the cytosol (37.9%), in tubular
cytosolic structures (93.6%), near the FV (5.8%), and at the parasite plasma membrane
(4.2%) (Fig. 1E; Table S1). At least some cytosolic AP-2-positive vesicles also contained
Rab5B, an effector of endosome-like transport between the plasma membrane and the
FV (Fig. S2) (41). Parasites expressing AP-2-2xFKBP-GFP showed a similar localization
and distribution by immuno-EM (Fig. S3; Table S1), but GFP ﬂuorescence was too faint
to reliably observe in live cells.
Plasmodium parasites lack a stacked Golgi apparatus, and differentiating the ER from
the Golgi apparatus by EM is difﬁcult. Therefore, AP-2-3xHA parasites were treated
with brefeldin A (BFA), a fungal metabolite and fast-acting inhibitor of ER-to-Golgi
secretory trafﬁc. Upon stimulation with BFA, proteins localized to, or trafﬁcked via, the
Golgi compartment relocalize to the ER. Previous studies examining intracellular trafﬁc
in Plasmodium have shown that parasite cultures remain viable when treated with
5 g/ml BFA for up to 24 h (42). After treating ring-stage parasites with 5 g/ml BFA for
16 h, AP-2-3xHA staining signiﬁcantly colocalized with staining observed for plasmep-
sin V, a luminal ER protease, suggesting AP-2 is localized to, or via, a secretory
membrane. AP-2 and plasmepsin V staining were distinct in solvent-treated controls
(see Fig. S4 in the supplemental material).
In recent studies, K13 has been localized to conspicuous membranous structures in
the cytosol near the FV (27) or plasma membrane (28), and these superﬁcially resemble
structures labeled by AP-2 here (Fig. 1D and E). Given the apparent similarity in
cellular distribution and importance of both molecules in ring-stage artemisinin sus-
ceptibility in vitro, we hypothesized that AP-2 and K13 localize to the same cytosolic
compartment. We overexpressed an episomally encoded N-terminal GFP-K13 fusion
protein in our AP-2-3xHA-expressing line and observed GFP-K13 signal resembling
that of previous studies (27). K13 and AP-2 displayed a striking similarity in signal
distribution in ring and schizont stages (Fig. 1F).
PfAP-2 is required for asexual replication. Given its proximity and localization at
the plasma membrane and to cytosolic vesicles, our data suggest a relationship
between AP-2 and the FV. However, the apparent presence of AP-2 in secretory ER
structures by EM appears to conﬂict with this model. To better characterize the role of
AP-2, we deployed an inducible DiCre system to study the impact of conditional pfap2
knockout (KO) in vitro (43). Speciﬁcally, the Cas9 donor constructs described above
were modiﬁed to insert both a loxP site into the 3= untranslated region (UTR) imme-
diately after the pfap2 stop codon and a loxP-containing pfsera2 intron into the 5= end
of the gene, 261 bp downstream of the translation start, such that Cre-mediated
excision removes the majority of the coding sequence, including the 3xHA tag. These
constructs were introduced into 3D7 parasites constitutively expressing dimerizable Cre
recombinase (44) (Fig. 2A).
Ring-stage cultures of the 3D7-AP-2-ﬂoxed-3xHA parasites were treated with 10 nM
rapamycin (rap) for 30 min to dimerize the split Cre recombinase and trigger pfap2
excision. Genomic DNA was extracted 24 h after this treatment, and PCR conﬁrmed
complete excision of the ﬂoxed region of pfap2 (Fig. 2B), resulting in ablation of AP-2
protein expression (Fig. 2C). Parasite counts by ﬂuorescence-activated cell sorting
(FACS) revealed that induced-KO of pfap2 prevented parasite replication within a
single asexual cycle, without appreciable recovery over multiple cycles (Fig. 2D),
showing that pfap2 is required for asexual replication in vitro. Importantly, the
Cre-mediated endogenous pfap2 KO was fully complemented with an episomally
expressed copy of AP-2-GFP under a constitutive promoter (Fig. 2E to G; Fig. S5). The
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ﬁnding that disruption of the  subunit is lethal conﬁrms that integration of the
C-terminal tandem HA tag on the  subunit does not signiﬁcantly disrupt the AP-2
complex, as our tagged parasites grew normally.
When examined by Giemsa staining, parasites lacking pfap2 arrest as malformed
schizonts which are still present in the culture at 60 h postinvasion (Fig. 2H). These
defective schizonts occupy approximately half of the red cell cytoplasm and contain
poorly segmented merozoites compared to wild-type schizonts. Consistent with re-
FIG 2 AP-2 is required for asexual replication and schizont maturation. (A) Schematic for the integration of loxP recombination elements into the endogenous
pfap2 locus of a parasite line constitutively expressing a split-Cre recombinase (43). The addition of rap initiates Cre dimerization and excision of the
loxP-ﬂanked (ﬂoxed) region of pfap2 on chromosome 12. (B) PCR conﬁrmation of rap-induced excision of ﬂoxed region by PCR using the primers P4 and P5
(see panel A). (C) Western blot conﬁrmation that excision of ﬂoxed pfap2 causes a loss of AP-2-3xHA protein (within 24 h) but has no effect on levels of CDC48
protein. Molecular weight is presented in kDa. (D) Parasite multiplication in the 3D7-AP-2-ﬂoxed-3xHA line across 2.5 cell cycles, with or without rap induction
of Cre. The mean parasitemia (normalized to 0.25% starting parasitemia) with the standard error is shown at each time point. Each data point represents the
average of at least three biological replicates (different cultures, different days). (E) PCR conﬁrmation of rap-mediated pfap2 excision in 3D7-AP-2-ﬂoxed-3xHA
parasites transfected with an episome encoding cam-AP-2-GFP. The construction of this complementation plasmid is described in Fig. S5. (F) Western blot
conﬁrmation that excision of chromosomal pfap2 from 3D7-AP-2-ﬂoxed-3xHA/cam-AP-2-GFP parasites causes a loss of AP-2-3xHA protein, but it does not
prevent episomal expression of AP-2-GFP. (G) Parasite multiplication in the 3D7-AP-2-ﬂoxed-3xHA/cam-AP-2-GFP line across 2.5 cell cycles, with or without
induction of Cre by rap. Means and standard errors are shown as in panel D. (H) Giemsa staining of 3D7-AP-2-ﬂoxed-3xHA schizonts, without rap treatment
at 48 h postinfection and with rap treatment at 48 and 60 h postinfection. (I) Electron micrograph of 3D7-AP-2-ﬂoxed-3xHA schizonts, with or without 1-h
ring-stage treatment with 10 nM rap. Micronemes at the apical end of developing merozoites are labeled with arrowheads; asterisks indicate membrane
separation (see Fig. S7). FV, food (digestive) vacuole; H, hemozoin; L, lipid body; M, merozoite; R, rhoptry. Scale bar, 500 nm.
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duced size, pfap2 KO schizonts carried fewer nuclei (mean  standard deviation [KO,
13.0 4.9; wild type, 19.3 4.8; P  0.0001; n 50 KO and 50 wild type]). As deter-
mined by FACS, the mean DNA content may be slightly lower in KO schizonts (mean 
standard deviation [KO, 18,180 8,900 U; wild type, 19,980 10,000 U; P  0.001;
n 21,924 events [KO] and 21,552 events [wild type]), but this difference is small and
does not explain the more than 45% difference in number of segmented nuclei
(Fig. S6). Rarely, rap-treated parasites were observed to undergo egress and invasion,
probably due to occasional failure to excise pfap2.
PfAP-2 is required for schizogony. Examining malformed AP-2-KO schizonts by
electron microscopy revealed gross morphological defects during schizogony and
merozoite biogenesis (Fig. 2I; Fig. S7). Merozoites forming within these schizonts are
highly disorganized and misshapen within the parasitophorous vacuole membrane,
and there are large pockets of schizont cytosol between the malformed merozoites. The
membranes seem indistinct, loosely encircling the deformed merozoites with irregular
invaginations not seen in wild-type parasites (Fig. 2I; Fig. S7), and were consistently
poorly preserved during ﬁxation and processing for electron microscopy despite sev-
eral replicate preparations. These bilayers tended to separate dramatically compared to
membranes in wild-type schizonts, and we cautiously attribute this observation to
membrane fragility in the absence of AP-2.
In addition, electron micrographs revealed a statistically signiﬁcant accumulation of
lipid bodies in the cytosol of AP-2 KO schizonts (Fig. 2I; Fig. S7), with some cells having
two, three, or four such bodies (Poisson regression: coefﬁcient, 0.597; 95% conﬁdence
interval [CI]  0.344 to 0.850; P  0.001; n 300 treated and 300 untreated). These
parasites were also more likely to contain aberrant FV that appeared fragmented or
elongated (odds ratio, 3.18; 95% CI  1.89 to 5.48; P  0.0001). Consistent with this,
apparently free hemozoin crystals were occasionally observed in the schizont cytosol.
Wild-type and KO trophozoites appear to be morphologically equivalent (Fig. S7), and
apicoplasts can be observed in these cells.
Subsequent IFA imaging supported these ﬁndings, since deletion of pfap2 disrupts
the biogenesis of several membrane-bound organelles (Fig. 3). Speciﬁcally, AMA1,
RON4, and CDC48, markers of the micronemes, rhoptries, and apicoplast, respectively,
are mislocalized by IFA, despite being detectable at normal levels by Western blotting
(Fig. S8). Despite this, rhoptries and micronemes are visible in some KO schizont EM
sections (Fig. 2I; Fig. S7), implying a defect in transport rather than organelle biogenesis.
In addition, in KO schizonts, MSP1 antibody staining is indistinct and fails to delineate
nascent merozoites, suggesting that invagination of the plasma membrane during
schizogony may be disrupted in the absence of AP-2 (Fig. 3). The parasitophorous
vacuole membrane, labeled by EXP2, seems to be largely intact though may have
discontinuities in some cells. The ER and cis-Golgi compartment display no obvious
abnormalities in cells lacking AP-2 (Fig. 3). Overall, it is unlikely that these widespread
defects are all directly attributable to AP-2, but rather that this complex phenotype
arises from knock-on effects of AP-2 deletion affecting downstream effector mole-
cules.
The AP-2 complex is clathrin independent and associates with Kelch10. To
identify AP-2 interacting partners, early schizont (32 to 36 h postinvasion) cell lysates
of P. falciparum AP-2-3xHA were prepared using cryomilling and detergent lysis, a cell
disruption technique that has generated high-resolution interactomes in other organ-
isms, although not previously deployed in Plasmodium (45). Using both Triton X-100
and CHAPS-containing lysis buffers, originally derived for the extraction of clathrin-
interacting proteins from Trypanosoma species, we lysed the frozen parasites, immu-
noprecipitated AP-2 using anti-HA-conjugated beads and performed mass spectrom-
etry (MS).
Since AP-2 is the canonical eukaryotic clathrin-interacting endocytic complex, we
expected AP-2 to interact with clathrin and the other AP-2 subunits in P. falciparum.
Indeed, all four AP-2 complex subunits were enriched under both lysis conditions
Henrici et al. ®
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tested, demonstrating that the complex in P. falciparum comprises subunits annotated
in the genome as AP-2, AP-2, AP-2 (our tagged bait protein), and AP-1, previously
predicted to be shared between the AP-1 and AP-2 complexes (Fig. 4A to C) (46, 47).
The latter subunit is therefore designated AP-1/2. Putative nucleotide-dependent
regulators of vesicular trafﬁc and a kelch-type beta-propeller domain protein encoded
on chromosome 10, K10, were also identiﬁed with high conﬁdence under one or both
lysis conditions (Fig. 4C; https://doi.org/10.17037/DATA.00001533). We conﬁrmed, by
Western blotting, that AP-2-3xHA copuriﬁes with episomally expressed and immuno-
precipitated K10-GFP but not similarly expressed cytosolic GFP (Fig. 4D). Despite little
FIG 3 AP-2-KO severely disrupts schizont maturation. (A) Antibodies against the ER (PMV), Golgi apparatus
(ERD2), PVM (EXP2), PPM (MSP1), IMC (GAP45, GAP50), apicoplast (CDC48), micronemes (AMA1), rhoptries (RON4),
episomal K13 (GFP), and AP-2 (HA) were used to stain 3D7-AP-2-ﬂoxed-3xHA schizonts with rap treatment (KO)
or without (wt). All organelle markers have been false colored green regardless of ﬂuorophore-conjugated
secondary antibody used for clarity. Nuclei have been false colored blue. IMC-TM, transmembrane component of
inner membrane complex. Scale bar, 2 m. (B and C) Abnormal labeling in AP-2 KO parasites was quantitated
relative to the staining observed in the majority of wild-type schizonts (B rap–; C rap). Normal staining was
deﬁned as follows: ERD2, PMV, and CDC48, discrete punctate staining corresponding to each nucleus; EXP2,
contiguous, circular, peripheral membrane staining; GAP45, GAP50, and MSP1, distinct, circular grape-like staining
surrounding each daughter nucleus; AMA1 and RON4, discrete, apical punctate spots corresponding to each
nucleus. At least 100 cells were scored for each marker.
P. falciparum Adaptor Complex 2 ®
January/February 2020 Volume 11 Issue 1 e02918-19 mbio.asm.org 7
 o
n
 February 27, 2020 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
sequence identity between K10 and K13, a codon 623 polymorphism in the locus
encoding K10 has been identiﬁed as coselected with K13 variants in artemisinin-
resistant parasites (48). K13 was not identiﬁed as an AP-2-interacting protein in our
immunoprecipitations. In addition, PfEHD, previously associated with endocytosis and
lipid storage, was enriched. Strikingly, neither the clathrin heavy chain (CHC; gene ID
PF3D7_1219100) nor the clathrin light chain (CLC; gene ID PF3D7_1435500) was
enriched in either extraction condition with our HA-tagged AP-2 (https://doi.org/10
.17037/DATA.00001533).
FIG 4 Identiﬁcation of AP-2-interacting proteins. (A) Volcano plot from P values versus the corresponding t test difference of proteins identiﬁed by
immunoprecipitation (IP) in Triton buffer. Cutoff curves for statistically signiﬁcant interactors (dotted curve) were calculated from the estimated false discovery
rate (for details, see Materials and Methods). Selected hits are labeled (potentially nonspeciﬁc interactors are in gray). (B) Volcano plot for proteins identiﬁed
by IP in CHAPS buffer. (C) Table of selected identiﬁed interactors listing functional annotation, enrichment ratios (compared to controls; see Materials and
Methods) and negative log10 of corresponding P values for Triton and CHAPS buffers, respectively. Additional hits are listed in an extended table available at
https://doi.org/10.17037/DATA.00001533. (D) pfk10-GFP (left panel) or GFP alone (right panel), driven by the calmodulin promoter, was expressed episomally
in 3D7-AP-2-3xHA parasites and immunoprecipitated with -GFP antibody-coated magnetic beads. Western blots of fractionated proteins are shown, probed
with either -GFP or -HA antibodies. Molecular weight is presented in kDa.
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To further validate our observation that AP-2 does not appear to interact with CHC,
we performed a similar analysis on a trophozoite preparation of parasites expressing
CHC-2xFKBP-GFP (Fig. 5A). All AP-1 complex components were enriched in these PfCHC
pulldowns, including AP-1/2, as were other trafﬁcking-associated components (Fig. 5B
and C; https://doi.org/10.17037/DATA.00001533). However, no peptides from AP-2 , ,
and  subunits were identiﬁed in MS analysis of four replicate pulldowns (Fig. 5B and
C). Given the dual presence of AP-1/2 as a component of both AP-1 and AP-2, we
consider the lack of additional AP-2 subunits in these immunoprecipitation (IP) exper-
iments to be strong evidence for the absence of an AP-2/CHC interaction. The lack of
AP-2 involvement in clathrin-dependent endocytosis has been demonstrated in African
trypanosomes, where the genes encoding the AP-2 subunits are absent and also
suggested in Trypanosoma cruzi, where clathrin does not appear to interact with AP-2
(45), but has never before been demonstrated in Plasmodium (34, 46). AP-3 complex
subunits were also identiﬁed, but they were not enriched compared to controls. The
role of the AP-4 complex is unclear in eukaryotes, but this complex is not believed to
interact with clathrin. Consistent with this, we did not detect peptides corresponding
to the P. falciparum AP-4 complex. Interestingly, peptides corresponding to Sortilin,
Vps9 (a DnaJ chaperone), and ring-stage infected erythrocyte surface antigen (RESA)
were enriched in the clathrin interactome, among other exported and trafﬁcking-
related factors. Collectively, these data suggest that retromer, trans-Golgi, and secretory
FIG 5 P. falciparum AP-2 does not interact with clathrin heavy chain. (A) Western blot of mixed-stage 3D7-CHC-2xFKBP-GFP lysates probed with antibodies,
either -GFP (left) or -PfCHC (right). (B) Volcano plot from P values versus the corresponding t test difference of proteins identiﬁed by -GFP (nanobody)
immunoprecipitation in CHAPS buffer. Cutoff curves for statistically signiﬁcant interactors (dotted curve) were calculated from the estimated false discovery rate.
(C) Abundance/enrichment ratio table for subunits of all adaptin subunits identiﬁed in the -CHC-GFP pulldown. Additional hits are listed in an extended table
available at https://doi.org/10.17037/DATA.00001533. ND, no peptides were detected that correspond to the listed protein. (D) Western blot of -PfCHC
immunoprecipitation performed on cryomilled 3D7-AP-2-3xHA trophozoite lysates. Membrane was probed with -PfCHC and -HA antibodies. (E) Maximum
intensity projection IFA of representative trophozoite and schizont stages of 3D7-AP-2-3xHA parasites, from among at least 100 cells examined at each stage,
probed with both -HA antibodies and -PfCHC, which are green and red in the merge images, respectively. Scale bar, 2 m. (F) Representative maximum
intensity projection images of time-lapse live microscopic observation of CHC-2xFKBP-GFP in a trophozoite. Each frame represents the passage of 6 min.
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trafﬁcking likely involve clathrin-coated vesicles (https://doi.org/10.17037/DATA.0000
1533).
The absence of interacting clathrin was further investigated by direct IP of CHC from
P. falciparum AP-2-3xHA lysates and Western blotting. We found no evidence that
AP-2-3xHA copuriﬁes with immunoprecipitated CHC (Fig. 5D). Using an anti-P. falci-
parum clathrin antibody, validated on a parasite line expressing PfCHC-2xFKBP-GFP
(Fig. 5A), we also found evidence by IFA that AP-2-3xHA and CHC are localized to
separate compartments (Fig. 5E). Consistent with our clathrin interactome, our local-
ization of PfCHC demonstrates many rapidly cycling foci decorating the plasma mem-
brane and cytoplasmic structures in live trophozoites (Fig. 5F). This dynamic localization
was never observed for AP-2 in our imaging studies. These data therefore support a
novel, clathrin-independent role for the AP-2 complex in Plasmodium.
DISCUSSION
We investigated the location and function of the  subunit of the AP-2 adaptor
complex in P. falciparum as a window into endocytosis, a major mechanism by which
the parasite ingests hemoglobin. This process supports parasite metabolism but also
provides the target of many frontline antimalarials. Little is known about endocytic
mechanisms in Plasmodium. Virtually all other eukaryotes exploit a clathrin-based
mechanism for sampling the extracellular space and uptake of speciﬁc molecules, and
we expected P. falciparum to utilize a similar machinery. This ﬁrst characterization of
AP-2 in apicomplexans highlights signiﬁcant divergence from eukaryotic canonical
endocytic mechanisms and previously established roles for AP-2 and clathrin.
Light-level imaging and immuno-EM localized the PfAP-2 complex to the plasma
membrane, as well as to distinct cytoplasmic foci, corresponding to vesicles near the FV
during intraerythrocytic development. These structures are visible throughout the
asexual cycle and replicate and segregate into merozoites during schizogony. By
colabeling immuno-EM, we show that a subset of these vesicles are also decorated with
Rab5B, a GTPase that regulates trafﬁc at the parasite plasma membrane, endosomes,
and digestive vacuole (41). Inhibition of intra-Golgi trafﬁcking with brefeldin A suggests
that AP-2 arrives at these locations via Golgi compartment-dependent vesicular trans-
port routes.
Importantly, our proteomic experiments deﬁned the AP-2 complex components in
P. falciparum as , , and  subunits plus the  subunit that participates in both AP-1
and AP-2 complexes. Genes encoding 1, 3, and 4 are annotated in the genome, and
there appears to be no discrete 2 (46), supporting a dual-purpose 1 in P. falciparum.
This promiscuous behavior has been reported previously in other organisms, where
1/2 has functional importance for targeting the vesicular complex to speciﬁc mem-
branes (47). Further work is required to determine whether this is also true of  in
Plasmodium, but it is clear that the protein is a bona ﬁdemember of both AP-1 and AP-2
complexes. Strikingly, we found no evidence of clathrin heavy or light chains in our
AP-2 interactome or of AP-2 subunits in our CHC interactome, which did include all
four components of AP-1 (34). Clathrin was localized to punctate structures throughout
the parasite cytosol, a distribution dramatically different to that for AP-2, consistent
with a lack of interaction (Fig. 5). A similar result was obtained for AP-2 in T. cruzi using
comparable techniques, suggesting clathrin and AP-2 may not be universally associ-
ated, as previously thought (45). These data imply that despite the shared  subunit,
which canonically links the AP complex to clathrin, other unknown P. falciparum
subunits or factors may be involved in the selection of coat proteins. These remain
unidentiﬁed for AP-2 but may lie among the many proteins of unknown function
identiﬁed in our AP-2 interactome, although no obvious coat scaffold proteins were
present (Fig. 4; http://datacompass.lshtm.ac.uk/1461/). Future studies should aim to
further deﬁne AP-2- and clathrin-mediated trafﬁc in Apicomplexa and establish
whether other adaptins perform diverged roles. Clathrin-independent AP-2 trafﬁcking
may prove widespread, since its occurrence in two very divergent protists suggests this
may be a more common phenomenon.
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Although we cannot deﬁne exactly the functions of AP-2 in Plasmodium, several
lines of evidence support a role in clathrin-independent endosomal transport, possibly
linked to the membrane recycling pathway. First, we colocalized AP-2 and Rab5B, a
mediator of FV and plasma membrane transport in P. falciparum, to discrete vesicles by
immuno-EM microscopy. These most likely represent a subset of endosomal structures.
Next, conditional deletion of AP-2 causes profound defects in membrane segregation,
lipid accumulation, and FV integrity during schizogony, ultimately causing arrest of
intraerythrocytic development. Although we do not observe the accumulation of red
blood cell (RBC) cytosol-containing vesicles at the plasma membrane, as observed in
“knock-sideways” experiments with the PIP3-linked kinase VPS45 (24), deletion of
AP-2 may block vesicular formation as AP-2 is responsible for selective concentration
of cargo into a nascent transport vesicle in most organisms where this has been
examined. In addition, parasites lacking AP-2 occupy less than half of the RBC cytosol,
a potential consequence of reduced endocytosis and disrupted growth. Lastly, our
proteomic investigation reveals AP-2 interacts with a number of vesicular cofactors,
including PfEHD, previously associated with endocytosis and lipid mobilization in P.
falciparum.
AP-2 conditional knockout leads to disruption and mislocalization of a subset of
proteins normally trafﬁcked to the apical secretory organelles of nascent merozoites.
Such mistargeting of cargo proteins is likely to have pleotrophic impacts as cellular
components fail to reach the correct compartment or are present at an inappropriate
level. Dissecting this in detail, using for example the knock-sideways strategy (27), will
allow more detailed interrogation of stage-speciﬁc effects of AP-2 depletion, as will
analysis of hemoglobin trafﬁcking.
Interestingly, though we found no evidence of a direct interaction between them,
we did ﬁnd that structures labeled by AP-2 overlap structures labeled by K13, the
major gene underlying artemisinin susceptibility in Southeast Asia (5). Yang et al.
recently demonstrated that K13 is localized to doughnut-shaped peripheral structures
resembling a collar of the cytostome, an endocytic invagination of the plasma and
parasitophorous vacuole membranes that delivers hemoglobin-rich host cell cytoplasm
to the FV (28). These observations are compatible with our results since hemoglobin-
ﬁlled vesicles, presumably deﬁned by AP-2 based on our results here, bud from the
distal cytostome and trafﬁc to the FV by an actin-myosin mechanism, and superreso-
lution methodologies might help resolve this localization and function (49, 50). In other
studies, K13 also localizes to PI3P-labeled structures implicated in modulation of
artemisinin susceptibility (25, 26). In Plasmodium, PI3P is a membrane component of
endocytic vesicles (24, 51). Thus, our ﬁndings and those of other investigators support
a role for endocytosis, hemoglobin ingestion, and more generally intracellular trafﬁc in
artemisinin susceptibility. First, K13 is the primary determinant of reduced susceptibility
in Southeast Asia and has now been implicated in cytostomal ingestion of host
cytoplasm (28). Second, mutations in the trafﬁcking adapter protein AP-2 are linked
to clinical responses to ACT in human infections and parasite artemisinin susceptibility
in vitro (8, 38–40). Third, mutations in the actin-binding protein Coronin also cause P.
falciparum ring-stage artemisinin resistance in vitro (52–54). Coronin has been linked to
regulation of endocytosis in Toxoplasma gondii (52). In addition, a mutation in AP-2
was recently identiﬁed in a laboratory-evolved lineage with reduced susceptibility to
artemisinin (55), and K10, an AP-2 interacting partner, has been implicated in the
complex multigenic signature of artemisinin susceptibility in Southeast Asia (48).
Further, a recent study showing that AP-2 and K13 are essential for a clathrin-independent
endocytic mechanism of ART resistance found no evidence of a direct interaction
between the two (56), which is consistent with our data. However, both studies found
PF3D7_081300 (KIC7) in the respective K13 and AP-2 interactomes, and thus KIC7 may
be a functional link between the two factors. These data justify further functional
studies of K13, AP-2, Coronin, PI3P, K10, and KIC7 toward a mechanistic understanding
of how cellular trafﬁcking components modulate artemisinin susceptibility in P. falci-
parum.
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Here, we show that AP-2 contributes to the processes of endocytosis and intra-
cellular trafﬁc during parasite development and is essential for intraerythrocytic schi-
zont maturation. Further deﬁning endocytosis in P. falciparum will provide key insights
into both the secretory system, which is important for replication, invasion and immune
evasion, and drug susceptibility. Our study provides the ﬁrst comprehensive scrutiny of
clathrin and AP-2 functions in Plasmodium and identiﬁes divergence from other eu-
karyotes that may be an important feature of the evolution of parasitism in apicom-
plexans.
MATERIALS AND METHODS
Plasmid design and construction. Plasmids pL6-AP2-3xHA-sgDNA and pL6-AP2-ﬂoxed-3xHA-
sgDNA encoding the donor sequences carried the tandem epitope tag and recombination elements
were created for transfecting 3D7 parasites as described previously (57). The coding sequence between
the epitope tag and upstream synthetic sera2 intron containing LoxP was recodonized to facilitate
efﬁcient homologous recombination (synthesis by Invitrogen) (43). These elements were cloned between
two 500-bp sequences homologous to the 5= UTR and the 3= UTR of pfap2.
Parasite culture and generation of transgenic parasites. Plasmodium falciparum culture was
performed as described previously (40). Two transfection methods were used in this study. For the
integration of single nucleotide polymorphisms, ring-stage transfection was performed. Brieﬂy, 3D7
parasites were cultured to approximately 10 to 15% parasitemia in 5% hematocrit under standard
conditions. Immediately before transfection, 100 g of each plasmid (pL6 and pUF1-Cas9) was ethanol-
acetate precipitated and resuspended in 100 l of sterile Tris-EDTA. Next, 300 l of infected RBC were
isolated by centrifugation and equilibrated in 1 Cytomix (120 mM KCl, 5 mM MgCl2, 25 mM HEPES,
0.15 mM CaCl2, 2 mM EGTA, 10 mM KH2PO4/K2HPO4 [pH 7.6]). Then, 250 l of packed cells was combined
with 250 l of 1 Cytomix in a 2-mm transfection cuvette (Bio-Rad Laboratories). The precipitated and
resuspended DNA was added to the cell suspension in the cuvette. The cells were immediately pulsed
at 310 V, 950 F, and inﬁnite resistance in a Bio-Rad Gene Pulser. The electroporated cells were then
washed twice in complete medium to remove debris and returned to culture. Fresh red blood cells were
added to approximately 5% total hematocrit on day 1 after transfection along with 2.5 nM WR99210 and
1.5 M DSM-1. Media and selection drugs were replenished every day for 14 days and then every 3 days
until parasites were observed by microscopy. Parasites recovered at approximately 3 weeks posttrans-
fection. The tagged 2 parasite line was created by the spontaneous DNA uptake method exactly as
described by Deitsch et al. (58). The 3D7-2-2xFKBP-GFP and 3D7-CHC-2xFKBP-GFP parasite lines,
generated via selection-linked integration (27), were generously provided by Tobias Spielmann. The 3D7
DiCre-expressing parasite line (43) was generously provided by Michael Blackman.
Fluorescence microscopy. Immunoﬂuorescence microscopy was performed on thin smears dried on
glass slides, ﬁxed for 10 min with 4% formaldehyde in phosphate-buffered saline (PBS), washed three
times with PBS, permeabilized with 0.1% (vol/vol) Triton X-100 in PBS for 10 min, washed again, and
blocked for 1 h with 3% (wt/vol) bovine serum albumin (BSA) in PBS. Primary antibodies were diluted in
PBS containing 3% (wt/vol) BSA and 0.1% (vol/vol) Tween 20 and then incubated on the slide overnight
at 4°C. The slides were again washed several times with PBS, incubated with secondary antibodies diluted
in the same buffer, incubated for 1 h at room temperature, and washed. Glass coverslips were mounted
with 1 l of Vectashield with DAPI (4=,6=-diamidino-2-phenylindole). Images were taken on a Nikon
TE-100 inverted microscope.
Electron microscopy. For ultrastructural analysis of 3D7-AP-2-ﬂoxed-3xHA, parasites were cultured
at 37°C in 4-ml volumes in six-well tissue culture dishes (Techno Plastic Products) at 2% hematocrit until
reaching 6 to 10% parasitemia. Cultures were synchronized until 80% of parasites were in ring-stage
growth and then treated for 1 h with 10 nM rap to excise pfap2. Cultures treated with dimethyl
sulfoxide (DMSO) were used as negative controls. Parasites were then washed twice with RPMI and
incubated at 37°C until harvesting. Synchronized parasites were magnetically sorted as either tropho-
zoite or schizont stages (MACS LD separation column; Miltenyi Biotech, Germany), collected by centrif-
ugation, and ﬁxed in 2% formaldehyde–2.5% glutaraldehyde (Polysciences, Inc., Warrington, PA) in
100 mM cacodylate buffer (pH 7.2) for 1 h at room temperature. The samples were washed in cacodylate
buffer and postﬁxed in 1% osmium tetroxide (Polysciences, Inc.) for 1 h. The samples were then rinsed
extensively in dH2O prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella, Inc., Redding, CA)
for 1 h. After several rinses in dH2O, the samples were dehydrated in a graded series of ethanol-water
mixes and embedded in Eponate 12 resin (Ted Pella, Inc.). Sections (90 nm) were cut with a Leica Ultracut
UCT ultramicrotome (Leica Microsystems, Inc., Bannockburn, IL), stained with uranyl acetate and lead
citrate, and viewed on a JEOL 1200 EX transmission electron microscope (TEM; JEOL USA, Inc., Peabody,
MA) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software
(Advanced Microscopy Techniques, Woburn, MA).
Immunoelectron microscopy. Parasites at 2% hematocrit and 6 to 8% parasitemia were magneti-
cally sorted from uninfected RBCs and ring-stage parasites as above, collected by centrifugation and
ﬁxed for 1 h at 4°C in 4% formaldehyde (Polysciences, Inc., Warrington, PA) in 100 mM PIPES–0.5 mM
MgCl2 (pH 7.2). Samples were then embedded in 10% gelatin, inﬁltrated overnight with 2.3 M sucrose–
20% polyvinyl pyrrolidone in PIPES-MgCl2 at 4°C, and ﬁnally trimmed, frozen in liquid nitrogen, and
sectioned with a Leica Ultracut UCT7 cryo-ultramicrotome (Leica Microsystems). Next, 50-nm sections
were blocked with 5% fetal bovine serum–5% normal goat serum (NGS) for 30 min, followed by
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incubation with a primary antibody for 1 h at room temperature (anti-PDI mouse, 1:100 [1D3; Enzo Life
Sciences]; anti-GFP rabbit, 1:200 [A-11122; Life Technologies]; anti-GFP mouse, 1:100 [11814460001;
Roche], anti-HA rabbit, 1:50 [H6908; Sigma-Aldrich]; and anti-Rab5A rabbit, 1:50, and anti-Rab5B rat, 1:50
[Gordon Langsley]). Secondary antibodies were added at 1:30 for 1 h at room temperature [12-nm
Colloidal Gold AfﬁniPure goat anti-rabbit IgG(HL) (111-205-144), 18-nm Colloidal Gold AfﬁniPure goat
anti-rabbit IgG(HL) (111-215-144), 12-nm Colloidal Gold AfﬁniPure goat anti-mouse IgG(HL) (115-
205-146), and 18-nm Colloidal Gold AfﬁniPure goat anti-mouse IgGIgM(HL) (115-215-068) (all from
Jackson ImmunoResearch)]. Sections were then stained with 0.3% uranyl acetate–2% methyl cellulose
and viewed on the JEOL TEM as described above. All labeling experiments were conducted in parallel
with controls omitting the primary antibody; these were consistently negative under the conditions used
in these studies.
Antibodies. Anti-HA (Roche, 3F10 clone) was obtained from the manufacturer. Anti-CHC (rabbit) anti-
bodies were donated by Frances Brodsky. We thank Gordon Langsley for making the anti-Rab5B antibodies
available. Anti-CDC48 and anti-AMA1 and anti-MSP1 antibodies were generously provided by Jude Przyborski
and Michael Blackman, respectively. Anti-GFP, anti-GAP45, and anti-BiP were supplied by Anthony Holder.
Anti-ERD2 was obtained from the MR4 repository. Secondary antibodies were either highly crossed adsorbed
ﬂuorophore conjugated (Invitrogen) or enzyme conjugated (Sigma). Primary and secondary antibodies were
used at 1:150 and 1:250, respectively, for IFA and at 1:5,000 and 1:5,000, respectively, for Western blot
experiments. Anti-CHC antibody was donated by Frances Brodsky and used at 1:500 for IFA and at 1:20,000
for Western blotting. All antibodies were generously donated by other laboratories and had been raised
against P. falciparum antigens with validation against lysates of cultured parasites. Cross-reactivity with other
Plasmodium species may occur with these reagents.
Pulldown and mass spectrometry. For lysate preparation, at 32 to 35 h postinvasion P. falciparum-
infected erythrocytes were grown to approximately 8% parasitemia at 5% hematocrit in approximately
6 liters of complete medium, sedimented, and lysed with 0.15% (wt/vol) saponin in PBS at 4°C. Parasites
were harvested by centrifugation at 13,000 rpm for 5 min at 4°C and then washed several times with cold
PBS to remove hemoglobin and red cell debris. The washed, packed parasites were resuspended to 50%
density in PBS, ﬂash frozen in liquid nitrogen, and stored at –80°C. This process was repeated until 6 to
8 ml of resuspended parasites had been stored. The frozen material was placed directly into the ball
chamber of a liquid N2-cooled cryomill (Retsch) and milled under seven cycles of 3 min of cooling and
3 min of milling. The milled powder was removed from the ball chamber and stored in liquid N2. All steps
were performed at or below –80°C to prevent parasite material from thawing. A 300-mg portion of the
milled powder per replicate was lysed in buffer A (20 mM HEPES, 100 mM NaCl, 0.1% [vol/vol] Triton
X-100, 0.1 mM TLCK [N-p-tosyl-L-lysine chloromethyl ketone], and protease inhibitors [Complete pro-
tease inhibitor cocktail tablet, EDTA-free, Roche]; pH 7.4) or buffer B (20 mM HEPES, 250 mM sodium
citrate, 0.1% [wt/vol] CHAPS, 1 mM MgCl2, 10 mM CaCl2, 0.1 mM TLCK, and protease inhibitors; pH 7.4).
Buffer B was previously optimized to immunoprecipitate clathrin heavy chain from trypanosomes (45).
The lysate was sonicated on ice with four cycles of 3 s on at 30% amplitude, followed by 10 s off and
clariﬁed by centrifugation. For 3D7-AP-2-3xHA, the soluble extract was incubated with 240 l of anti-HA
magnetic beads (Pierce, Thermo Fisher) for 1 h. The beads were washed three times with lysis buffer, and
bound material was eluted by suspending the beads in 80 l of nonreducing LDS buffer (Invitrogen) and
incubating at 70°C for 10 min. After the beads were removed, NuPAGE sample-reducing agent (Thermo
Fisher) was added to the supernatant.
The PfCHC-2xFKBP-GFP soluble extract in buffer B was incubated with 4 l of recombinant anti-GFP
nanobodies covalently coupled to surface-activated Epoxy magnetic beads (Dynabeads M270 Epoxy,
Thermo Fisher) for 1 h, washed three times in buffer B and eluted in 80 l of LDS buffer (Invitrogen),
supplemented with NuPAGE, at 70°C for 10 min. The eluates were concentrated in a Speed-Vac to 30 l
and run approximately 1.2 cm into an SDS-PAGE gel. The respective gel region was sliced out and
subjected to tryptic digest, reductive alkylation. Eluted peptides were analyzed by liquid
chromatography-tandem mass spectrometry on a Dionex UltiMate 3000 RSLCnano System (Thermo
Scientiﬁc, Waltham, MA) coupled to an Orbitrap Q Exactive mass spectrometer (Thermo Scientiﬁc) at
the University of Dundee Finger-Prints Proteomics facility. Mass spectra were processed using
MaxQuant version 1.5 by the intensity-based label-free quantiﬁcation (LFQ) method (59, 60). The
minimum peptide length was set at six amino acids, and false discovery rates of 0.01 were calculated
at the levels of peptides, proteins, and modiﬁcation sites based on the number of hits against the
reversed sequence database. Ratios were calculated from LFQ intensities using only peptides that
could be uniquely mapped to a given protein across two (AP-2 CHAPS) or four (AP-2 Triton, CHC
CHAPS) replicates of each treatment/bait protein combination. The software Perseus was used for
statistical analysis of the LFQ data (60). Extended proteomic data tables are available at https://doi
.org/10.17037/DATA.00001533.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, TIF ﬁle, 2.2 MB.
FIG S2, TIF ﬁle, 1 MB.
FIG S3, TIF ﬁle, 2.3 MB.
FIG S4, TIF ﬁle, 0.3 MB.
FIG S5, TIF ﬁle, 0.4 MB.
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FIG S6, TIF ﬁle, 2.1 MB.
FIG S7, TIF ﬁle, 1.3 MB.
FIG S8, TIF ﬁle, 0.1 MB.
TABLE S1, DOCX ﬁle, 0.02 MB.
TABLE S2, DOCX ﬁle, 0.1 MB.
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